Myocardial Contrast Echocardiography for the Assessment of the Infarct Related Artery & Risk Area in Patients w/ NSTEMI.

Status unconfirmed · Not applicable

Conditions studied: STEMI

In brief

The goal of this study will be to assess the incremental benefit of myocardial contrast echocardiography for the assessment of regional wall motion abnormalities and infarct-related artery in patients presenting with their first NSTEMI.

Key facts

Study ID

NCT02014701

Run by

Cedars-Sinai Medical Center

People needed

100

Starts

2012-08-01

Expected to finish

2014-03-01

Last updated by the study team

2013-12-18

Who can join

Age: 31 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients presenting with NSTEMI who are scheduled to undergo elective cardiac catheterization and coronary angiography with primary PCI

You may not qualify if…

• Inability to undergo a contrast echocardiogram Unwillingness to consent to a contrast echocardiogram

Where it is running

• Cedars-Sinail Medical Center — Los Angeles, California, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.